Gene therapy for asthma.

Abstract excerpt

The accessibility of the airway epithelium and the limitations of current treatments for asthma make the disease a logical target for gene therapy. Study of the immunopathology of chronic airway inflammation has recently identified several pathways that lead to the maladaptive, antigen-induced polarization of CD4+ T cells to a type-2 phenotype. This polarization is thought to lead to IgE production and eosinophil...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Th2 Cells
• Share to Interleukin-12
• Share to Receptors, Adrenergic, beta